New chemoradiotherapy combinations in head and neck cancer

References

• Breau RL, Clayman GL. Gene therapy for head and neck cancer. CUI 7: Opin. Oncol 8, 227–231 (1996).
   Google Scholar
• Vokes EE, Weichselbaum RR, Lippman SM et al. Head and neck cancer. N Engl. J. Med. 328,184–194 (1993).
   PubMed Web of Science ®Google Scholar
• Pignon JP, Bourthis J, Domenge C et al Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analysis of updated individual data. Lancet 355,949–955 (2000).
   PubMed Web of Science ®Google Scholar
• ••Important and comprehensive meta-analysis indicating the superiority of chemoradiotherapy.
   Google Scholar
• El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. j Oncol 14(3), 838–47 (1996). A historically important meta-analysis.
   Google Scholar
• Hoffmann W, Belka C, Schmidberger H et al Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer: results from a Phase I trial. Int. J. Radiat. Oncol Rio. Phys38, 691–696 (1997).
   Google Scholar
• Feher O, Martins SJ, Lima CA et al. Pilot trial of concurrent chemotherapy with paditaxel and conventional fractionated irradiation in advanced unresectable squamous cell carcinoma. Pmceedings of the 36th Annual Meeting of American Society of Clinical Oncology New Orleans, USA, Abstract 1694 (2000).
   Google Scholar
• Bouillet T, Morere J, Despreaux D et al Concurrent radiotherapy and paditaxel twice a week as radiosensitizer in stage III—IV Head and Neck carcinoma. Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology New Orleans, USA, Abstract 1670 (2000).
   Google Scholar
• Tishler RB, Busse PM, Norris C et al An initial experience using concurrent paclitaxel and radiotion in the treatment of head and neck malignancies. Int. J. Radiat. Oncol Rio. Phys 43, 10001–1008 (1999).
   Google Scholar
• Steinberg L, Hassn M, Olmsted L et al. A Phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma. Semin. Oncol 24\(Suppl. 19), 51–56 (1997).
   Google Scholar
• Doyle T, Devine P, Rosenthal DI et al. A Phase VII trial of accelerated radiotherapy plus concurrent 96-hour Paclitaxel infusion for unresectables squamous cell carcinoma of the head and neck. Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology New Orleans, USA, Abstract 1676 (2000). itConley B, Jacobs M, Suntharalingam M et al A pilot trial of paclitaxel, carboplatin and concurrent radiotherapy for unresecTable squamous cell carcinoma of the head and neck. Semin. Oncol 24\(Suppl. 19), 78–80 (1997).
   Google Scholar
• Bahri S, Agarwala SS, Cano E et al. Phase II study of weekly carboplatin and paclitaxel concurrent with radiation therapy in patiens with locally advanced, inoperable squamous cell carcinoma of the head and neck. Pmceedings of the 36th Annual Meeting of American Society of Clinical Oncology New Orleans, USA, Abstract 1667 (2000).
   Google Scholar
• Chougule PB, Akhtar MS, Akerley W et al. Chemoradiotherapy for advanced inoperable head and neck cancer: A Phase II study. Semin. Radiat. Oncol 9\(Suppl. 1), 58–63 (1999).
   Google Scholar
• Brockstein B, Haraf DJ, Stenson K et al. A Phase I—II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granuloyte colony stimulating factor support for patients with poor prognosis head and neck cancer. Ann. Oncol 11,721–728 (2000).
   Google Scholar
• •Interesting Phase I-11 study of chemoradiotherapy with paclitaxel and high activity.
   Google Scholar
• Merlano M, Vitale V, Rosso R et al Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl. J. 114ed. 327, 1115–1121 (1992).
   Google Scholar
• Koukourakis M, Bizakis J, Skoulakis C et al Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. Anticancer Res. 19,2305–2309 (1999).
   PubMedGoogle Scholar
• Budach W, Hehr T, Belka C et al. Alternating chemo-radiation with docetaxel (D)/cisplatin (C) and involved field radiotherapy for recurrent, inoperable and previously irradiated head & neck cancer. Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology New Orleans, USA, Abstract 1649 (2000).
   Google Scholar
• Humerickhouse RA, Haraf D, Stenson B et al. Phase I study of irinotecan, 5-FU and hydroxyurea with radiation in recurrent or advanced head and neck cancer. Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology New Orleans, USA, Abstract 1650 (2000).
   Google Scholar
• •A Phase I study of a new drugs in the chemoradiotherapy of HNSCC.
   Google Scholar
• Eisbruch A, Shewach DS, Urba S et al. Phase I trial of radiation concurrent with low-dose gemcitabine for head and neck cancer: High mucosal and pharyngeal toxicity. Proceedings of the 33th Annual Meeting of American Society of Clinical Oncology Denver, USA, Abstract 1377 (1997).
   Google Scholar
• Eisbruch A, Shewach DS, Bradford CR et al. Radiation concurrent with low dose gemcitabine for head and neck cancer: Interim results of a Phase I study. Proceedings of the 34th Annual Meeting of American Society of Clinical Oncology Los Angeles, USA, Abstract 1563 (1998).
   Google Scholar
• Jaremtchuk V, Zarba JJ, Keropian M et al. Phase I study of gemcitabine combined with radiotherapy with or without amifostine in patients with locally advanced head and neck cancer. Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology New Orleans, USA, Abstract 1674 (2000).
   Google Scholar
• Humerickhouse RA, Haraf D, Brockstein et al. Phase I study of gemcitabine, 5-FU and paclitaxel with RT in recurrent or advanced head and neck cancer. Proceedings of the 35th Annual Meeting of American Society of Clinical Oncology Atlanta, USA, Abstract 1531 (1999).
   Google Scholar
• Benasso M, Medan° M, Sanguineti G et al. Gemcitabine, cisplatin and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study. Am. Clin. Oncol, (In Press).
   Google Scholar